Page last updated: 2024-09-24

6-alpha-methyl-progesterone

Description

6-alpha-methyl-progesterone: a synthetic derivative of PROGESTERONE; with anti-androgenic & synandrogenic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92847
CHEBI ID34476
SCHEMBL ID7978305
MeSH IDM0074083

Synonyms (31)

Synonym
pregn-4-ene-3, 6.alpha.-methyl-
903-71-9
pregn-4-ene-3, 6-methyl-, (6.alpha.)-
nsc-75530
nsc75530
6.alpha.-methylprogesterone
6-alpha-methylprogesterone
(6alpha)-6-methylpregn-4-ene-3,20-dione
(6-alpha)-6-methylpregn-4-ene-3,20-dione
pregn-4-ene-3,20-dione, 6alpha-methyl-
pregn-4-ene-3,20-dione, 6-methyl-, (6-alpha)-
nsc 75530
6-alpha-methylpregn-3-ene-3,20-dione
pregn-4-ene-3,20-dione, 6-methyl-, (6alpha)-
pregn-4-ene-3,20-dione, 6-alpha-methyl-
6alpha-methylprogesterone
6alpha-methylpregn-4-ene-3,20-dione
6-alpha-methyl-progesterone
unii-ykt998y6uz
ykt998y6uz ,
methylprogesterone, 6.alpha.
pregn-4-ene-3,20-dione,6.alpha.-methyl-
SCHEMBL7978305
6a-methyl-4-pregnene-3 ,20-dione
CHEBI:34476
pregn-4-ene-3,20-dione, 6-methyl-, (6.alpha.)-
pregn-4-ene-3,20-dione, 6.alpha.-methyl-
6-.alpha.-methylpregn-3-ene-3,20-dione
GNFABWAPJFOZSF-KTORGGLSSA-N
Q27116095
DTXSID601294866

Drug Classes (1)

ClassDescription
corticosteroid hormoneAny of a class of steroid hormones that are produced in the adrenal cortex.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]